\nAs a pioneer of precision medicine for genetic disorders and rare diseases, a California-based biotech company wanted to develop an innovative platform for targeted therapies while outsourcing manufacturing and testing.\n<\/p>\n
\nBut this model immediately presented hurdles. Managing vast volumes of inconsistent, paper-based data from its global partner network made data retrieval and organization extremely challenging. With commercialization on the horizon, the company needed a modern technology foundation to streamline quality control (QC) for rapid regulatory filings, inspection readiness, and reduced time to market.\n<\/p>\n
\nToday, the biotech benefits from a right-sized solution that grows alongside its business needs. By implementing ³Ô¹Ï±¬ÁÏ LIMS<\/a>, it successfully transitioned to an industry-specific and unified platform, simplifying QC lab data management and test execution processes. As a result, quality management is now more efficient, scalable, and fully integrated across the product development lifecycle.\n<\/p>\n \nAs a virtual organization, the biotech relies heavily on external partners for manufacturing and testing. These partners generate critical product quality and stability data for review and inclusion in regulatory filings, but also historically operated in silos: “We ingest a lot of data from our vendors, and it comes in various formats at different times,” explains the biotech\u2019s IT director. \u201cThe lack of consistency and standardization makes it nearly impossible to find and organize our data,\u201d she adds.\n<\/p>\n \nChanges from vendors often went unnoticed. Data consolidation was a manual, labor-intensive process, preventing effective QC and slowing down biologics license applications (BLA). As the company prepared for commercialization, it realized it needed to remove silos for greater transparency, speed, and inspection readiness.\n<\/p>\n \nTo reduce complexity and streamline QC, the biotech selected ³Ô¹Ï±¬ÁÏ LIMS<\/a> as its technology foundation. Already a customer of ³Ô¹Ï±¬ÁÏ Quality Cloud and other ³Ô¹Ï±¬ÁÏ Development Cloud applications, it was able to unify QA, QC, and training on ³Ô¹Ï±¬ÁÏ Vault Platform.\n<\/p>\n \nThe company immediately saw an opportunity to accelerate time to market by simplifying processes and collaborating more effectively during testing and manufacturing. \u201cEverything we do, especially when it comes to introducing new solutions, is about inspection readiness, commercialization, and at the end of the day, helping our patients,\u201d emphasizes the IT director.\n<\/p>\n \nBecause ³Ô¹Ï±¬ÁÏ LIMS is a purpose-built solution, only role-specific tools required by each user are surfaced, ensuring a straightforward experience. \u201cUnlike traditional systems cluttered with unnecessary functionality, ³Ô¹Ï±¬ÁÏ LIMS users only see what they need. It\u2019s a right-sized solution requiring very little configuration,\u201d explains the IT director. This streamlined design ensures the system remains low maintenance for a lean IT team and simplifies future enhancements.\n<\/p>\n \nAt the same time, minimal configuration often translates to faster validation. \u201cI don’t have to worry about massive amounts of validation because I didn’t customize,\u201d says the IT director. \u201cLeveraging ³Ô¹Ï±¬ÁÏ validation packages was huge. Using pre-validated materials, we significantly reduced the resources required for implementation,\u201d she highlights.\n<\/p>\n \nThe integration of ³Ô¹Ï±¬ÁÏ LIMS with other industry-specific applications also built on Vault Platform<\/a> \u2014 including RIM<\/a>, QualityDocs<\/a>, QMS<\/a>, and Training<\/a> \u2014 means the organization can easily connect data and content across functions. The team is also working to connect certificates of analysis (CoA) from LIMS directly to RIM so regulatory teams have immediate access to critical documents without leaving their primary workspace.\n<\/p>\n \nUsing a digital-first system has fundamentally changed how the biotech manages and leverages QC data.\n<\/p>\n \nDuring its transition, the team rigorously evaluated data definitions, leading to a level of standardization that was previously unattainable. Because data is standardized, the company is able to link and report on data across systems with accuracy and reliability, supporting rapid decision-making and audit readiness. \u201cIt forced us to evaluate our data and clarify how we identify and define things. Now, we are consistent across the board, which will significantly help us in the future,\u201d explains the IT director.\n<\/p>\n \nSimplified processes and a cohesive user experience accelerate training and adoption. \u201cA single look and feel makes training easier because users already know what to expect,\u201d says the IT director. \u201cPreviously, the entire technical operations team of over 80 people was required to complete the same 30 standard operating procedures (SOPs). Under the new system, most employees now only train on five to 10 meaningful documents,\u201d she adds.\n<\/p>\n \nBy eliminating up to 80% of unnecessary training, the company has freed up valuable QC time. Scientists and quality teams can redirect their energy toward critical procedures that advance the company’s core mission. “That time can now be spent doing what our scientists do best: working to improve patients’ lives,” the IT director notes.\n<\/p>\n \nIn the long term, every successful digital transformation is underpinned by partnership. “What really impressed me is the fact that ³Ô¹Ï±¬ÁÏ took our feedback seriously, directly influencing the product development and ensuring ³Ô¹Ï±¬ÁÏ LIMS capabilities serve our growing needs,” says the IT director. \u201cThis partnership drives consistent innovation as the ³Ô¹Ï±¬ÁÏ team actively seeks to understand what is important to the customer. This is what makes ³Ô¹Ï±¬ÁÏ unique in the industry\u201d.\n<\/p>\n \n“Unlike traditional systems cluttered with unnecessary functionality, ³Ô¹Ï±¬ÁÏ LIMS is a right-sized solution requiring very little configuration.\u201dSiloed operations increase QC data complexity<\/h2>\n
Transition to unified and connected QC<\/h2>\n
Freeing up experts for mission-critical work<\/h2>\n
\n\u2013 IT Director, Biotech Company<\/span>\n<\/p><\/blockquote>\n